Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
8.03
+0.05 (0.62%)
Nov 21, 2024, 1:53 PM EST - Market open
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $500.20 million as of November 21, 2024. Its market cap has decreased by -27.04% in one year.
Market Cap
500.20M
Enterprise Value
484.45M
1-Year Change
-27.04%
Ranking
Category
Stock Price
$8.03
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $500.20M, a decrease of -43.78%. That is a compound annual growth rate of -14.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 497.13M | -36.78% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL | 496.96M |
| PureTech Health | 491.58M |
| Arcturus Therapeutics Holdings | 489.20M |
| Theravance Biopharma | 487.81M |
| Y-mAbs Therapeutics | 486.41M |
| Zevra Therapeutics | 478.78M |
| Esperion Therapeutics | 474.85M |
| REGENXBIO | 473.65M |